SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ARIAD Pharmaceuticals
An SI Board Since September 1996
Posts SubjectMarks Bans Symbol
4474 134 0 ARIA
Emcee:  jaybe Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
4274Wouldn't the median time on treatment (25 weeks Arm A, 23 weeks Arm B) implyghmm-5/19/2016
4273TBH, with Ariad, statements like "very strange way to report things" mglass 0.5 full-5/19/2016
4272>>but if 75% of patients in Arm B have not experienced progression at 11.1Biomaven-5/19/2016
4271Please correct me if I'm wrong, but if 75% of patients in Arm B have not expjaybe-5/18/2016
4270New IST for pona + chemo in newly diagnosed Ph+ALL... Spanish consortium to usejaybe-5/18/2016
4269A few highlights from the pona abstracts... abstracts.asco.org Conclusions: Deejaybe-5/18/2016
4268So higher dose briga results (albeit not yet fully mature) are noticeably betterBiomaven-5/18/2016
4267From the press release (emph added): "The first early results are now avaiglass 0.5 full-5/18/2016
4266Some ASCO abstracts: Impact of landmark responses on 3-year (yr) outcomes with glass 0.5 full-5/18/2016
4265Snapshot of Univ. Colo. screening protocols suggests broader use for pona... Onjaybe15/15/2016
4264ALTA-1L trial (briga v. criz) now recruiting at Univ. of Colorado... Dr. Ross Cjaybe-5/13/2016
4263Thanks Glass for the efforts, and Jaybe, I sure hope you have decided to engage tktom-5/12/2016
4262"I, for one, welcome our new message board overlord." [graphic]glass 0.5 full25/11/2016
4261Results of the poll indicate that jaybe received the plurality vote with Biomaveglass 0.5 full-5/11/2016
4260a very well structured deal to provide the funding needed to bridge the financinVidpok1-5/10/2016
4259Biomaven, there was a lot of infrastructure in this deal (135 employees, and a ftktom-5/10/2016
4258That's how I heard it described on the call -- buy-back option is available glass 0.5 full-5/10/2016
4257Very nice deal with Incyte. It's hard to break down how much they paid forBiomaven45/10/2016
4256Maybe I did not read the agreement correctly, but unless I misunderstood ARIA catestad-5/10/2016
4255nice gain on big volume. Probably short covering. Bodes well for the months aVidpok1-5/10/2016
4254CC Transscript. seekingalpha.comcivic08801-5/10/2016
4253According to an SC 13G/A filing that was registered with the SEC today, Putnam Ibmaz001-5/10/2016
4252uh oh. Looks like the buyout figure just went up. The magic number now is (drVidpok1-5/10/2016
4251Thank you , Glass 1/2flexinvesting-5/10/2016
4250I put together a survey: Link to Board Admin Recommendation Vote: surveymonkey.glass 0.5 full-5/10/2016
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News